Pure Bioscience Financials

Pure Bioscience Stock Summary

Pure Bioscience competes with Kimberly Clark, Colgate Palmolive, Unilever PLC, Estee Lauder, and Clorox. PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California. PURE BIOSCIENCE operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 10 people.

Pure Bioscience Key Financial Ratios

There are many critical financial ratios that Pure Bioscience's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Pure Bioscience reports annually and quarterly.

Pure Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Pure Bioscience's current stock value. Our valuation model uses many indicators to compare Pure Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pure Bioscience competition to find correlations between indicators driving Pure Bioscience's intrinsic value. More Info.Pure Bioscience is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pure Bioscience's earnings, one of the primary drivers of an investment's value.

Pure Bioscience Market Pulse

Along with financial statement analysis, the daily predictive indicators of Pure Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pure Bioscience. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pure Bioscience based on widely used predictive technical indicators. In general, we focus on analyzing Pure Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pure Bioscience's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

If you are still planning to invest in Pure Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pure Bioscience's history and understand the potential risks before investing.